These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21342375)

  • 41. Availability of Essential Medicines in a Country in Conflict: A Quantitative Insight from Yemen.
    Mohamed Ibrahim MI; Alshakka M; Al-Abd N; Bahattab A; Badulla W
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33383771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No deal in sight on cheap drugs for poor countries.
    Fleck F
    Bull World Health Organ; 2003; 81(4):307-8. PubMed ID: 12764500
    [No Abstract]   [Full Text] [Related]  

  • 43. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 44. Assessment of the impact of market regulation in Mali on the price of essential medicines provided through the private sector.
    Maïga D; Williams-Jones B
    Health Policy; 2010 Oct; 97(2-3):130-5. PubMed ID: 20435368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Access for all to quality drugs].
    Videau JY
    Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmaceutical Services and comprehensiveness 30 years after the advent of Brazil's Unified Health System.
    Bermudez JAZ; Esher A; Osorio-de-Castro CGS; Vasconcelos DMM; Chaves GC; Oliveira MA; Silva RMD; Luiza VL
    Cien Saude Colet; 2018 Jun; 23(6):1937-1949. PubMed ID: 29972501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran.
    Cheraghali AM; Nikfar S; Behmanesh Y; Rahimi V; Habibipour F; Tirdad R; Asadi A; Bahrami A
    East Mediterr Health J; 2004 May; 10(3):406-15. PubMed ID: 16212218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The essential drugs program in Haiti].
    Benitez AJ
    Sante Publique; 1998 Dec; 10(4):401-12. PubMed ID: 10065006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Access to medicines by patients of the primary health care in the Brazilian Unified Health System.
    Álvares J; Guerra AA; Araújo VE; Almeida AM; Dias CZ; Ascef BO; Costa EA; Guibu IA; Soeiro OM; Leite SN; Karnikowski MGO; Costa KS; Acurcio FA
    Rev Saude Publica; 2017 Nov; 51(suppl 2):20s. PubMed ID: 29160463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Medicine supplies in developing countries: saving public medicine procurement bodies in Africa].
    Barbereau S
    Med Sante Trop; 2013; 23(3):251-5. PubMed ID: 24126191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Essential medicines for pediatric oncology in developing countries.
    Mehta PS; Wiernikowski JT; Petrilli JA; Barr RD;
    Pediatr Blood Cancer; 2013 May; 60(5):889-91. PubMed ID: 23450774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 53. Private pharmacy practice and regulation. A randomized trial in Lao P.D.R.
    Stenson B; Syhakhang L; Lundborg CS; Eriksson B; Tomson G
    Int J Technol Assess Health Care; 2001; 17(4):579-89. PubMed ID: 11758301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Essential medicines and access to primary health care in the medical district of Mambéré-Kadéï].
    Mouala C; Abeye J; Goumba A
    Sante; 2009; 19(4):175-9. PubMed ID: 20172844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: analysis of the effect of TRIPs-Plus proposal.
    Akaleephan C; Wibulpolprasert S; Sakulbumrungsil R; Luangruangrong P; Jitraknathee A; Aeksaengsri A; Udomaksorn S; Tangcharoensathien V; Tantivess S
    Health Policy; 2009 Jul; 91(2):174-82. PubMed ID: 19150741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deadlock on access to cheap drugs at global trade negotiations.
    Hagmann M
    Bull World Health Organ; 2003; 81(2):150-1. PubMed ID: 12751424
    [No Abstract]   [Full Text] [Related]  

  • 57. The global-local dilemma of a Ministry of Health experiences from Uganda.
    Jeppsson A; Birungi H; Ostergren PO; Hagström B
    Health Policy; 2005 Jun; 72(3):311-20. PubMed ID: 15862639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the selection of medicines for the Brazilian primary health care.
    Karnikowski MGO; Galato D; Meiners MMMA; Silva EVD; Gerlack LF; Bós ÂJG; Leite SN; Álvares J; Guibu IA; Soeiro OM; Costa KS; Costa EA; Guerra AA; Acurcio FA
    Rev Saude Publica; 2017 Nov; 51(suppl 2):9s. PubMed ID: 29160450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An exploratory study on equity in funding allocation for essential medicines and health supplies in Uganda's public sector.
    Kusemererwa D; Alban A; Obua OT; Trap B
    BMC Health Serv Res; 2016 Aug; 16(1):453. PubMed ID: 27577997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.